Work

A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.7165

Authors: M. A. Socinski, C. H. Weissman, L. L. Hart, J. T. Beck, J. K. Choksi, J. P. Hanson, D. Prager, L. P. Bloss, Z. Ye, C. K. Obasaju

Institutions: University of North Carolina at Chapel Hill, University of California, Los Angeles, Eli Lilly (United States), Highlands Oncology Group, New York Oncology Hematology

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2288014069

Cites:

Cited by: 6

Related to: 10